Cysteine engineered anti-TENB2 antibodies and antibody drug conjugates

Details for Australian Patent Application No. 2008312457 (hide)

Owner GENENTECH, INC.

Inventors Junutula, Jagath Reddy; Polakis, Paul; Mao, Weiguang

Agent Griffith Hack

Pub. Number AU-A-2008312457

PCT Pub. Number WO2009/052249

Priority 60/981,411 19.10.07 US

Filing date 16 October 2008

Wipo publication date 23 April 2009

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/052249 Priority application(s): WO2009/052249

10 June 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 11 May 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008312464-Novel therapeutic targets in bowel disease

2008312444-Use of MVA to treat prostate cancer